Results 201 to 210 of about 76,618 (225)

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Lancet, The, 2000
Philip J Mease
exaly  

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Lancet, The, 2013
Josef S Smolen, Peter Nash, Patrick Durez   +2 more
exaly  

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Lancet, The, 2006
Stephen K Tyring
exaly  

Drug-induced systemic lupus erythematosus associated with etanercept therapy

Lancet, The, 2002
Joel A Block
exaly  

Etanercept

Reactions Weekly, 2021
openaire   +1 more source

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Lancet, The, 2004
Lars Klareskog, Karel Pavelka
exaly  

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

Lancet, The, 2008
Paul Emery, Patrick Durez
exaly  

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Lancet, The, 2015
Christopher E M Griffiths, Kristian Reich, Mark G Lebwohl   +2 more
exaly  

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Lancet, The, 2017
Kristian Reich, Ka Papp, Andrew Blauvelt
exaly  

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Lancet, The, 2015
Hervé Bachelez, Peter C M Van De Kerkhof, Alexey Kubanov   +2 more
exaly